Want to see MRAI full AI Analyst Report?
MRAI Stock Chart & Stats
$0.73
-$0.08(-7.69%)
At close: 4:00 PM EST
$0.73
-$0.08(-7.69%)
Day’s Range― - ―
52-Week Range$0.22 - $2.25
Previous CloseN/A
Volume51.03K
Average Volume (3M)20.43K
Market Cap
$56.91M
Enterprise Value$8.24
Total Cash (Recent Filing)$201.00K
Total Debt (Recent Filing)$730.00K
Price to Earnings (P/E)―
Beta-0.61
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.87
Shares Outstanding25,292,667
10 Day Avg. Volume21,648
30 Day Avg. Volume20,435
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-0.34
Price to Sales (P/S)0.61
P/FCF Ratio-1.47
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
AI-powered TPA PlatformMarpai’s technology-enabled, AI-focused TPA business is structurally well-aligned with employers’ long-term need to control healthcare spend. Recurring administrative fee models and data-driven cost management can create sticky client relationships, improve per-client margins over time, and support scaled unit economics if adoption grows.
Debt-service Relief Via RestructuringMaterial reduction in near-term debt service and extended maturities materially lowers refinancing and liquidity pressure. This structurally improves cash flow timing, freeing capital to invest in product, operations and sales execution, and reduces the immediate risk that operating deficits force distressed financing decisions.
Low Reported TTM DebtRelatively low reported debt on a TTM basis reduces immediate interest and covenant risk, giving management incremental flexibility to prioritize growth and technology investment. When combined with the restructuring, a lighter debt burden can extend runway and lessen the probability of near-term solvency-driven disruptions.
Bears Say
Negative Shareholder EquityPersistently negative equity signals accumulated losses that have eroded the capital base, limiting the firm’s ability to absorb shocks and increasing dependence on external capital. Negative equity heightens refinancing and dilution risk and can constrain access to traditional debt or partner arrangements over the medium term.
Heavy Cash BurnSustained negative operating and free cash flow indicates the business is not self-funding and will likely need continued external financing. Ongoing cash burn limits discretionary investment in sales and product, increases dilution or leverage risk, and raises the probability that future growth is interrupted if funding access tightens.
Declining Revenue & Extreme LossesDeclining top-line and near-total negative margins reflect poor operating leverage and difficulty scaling the model profitably. Structural revenue contraction and very large losses undermine competitive positioning, reduce reinvestment capacity, and make achieving sustainable profitability more challenging without clear, repeatable revenue recovery.
Marpai News
MRAI FAQ
What was Marpai’s price range in the past 12 months?
Marpai lowest stock price was $0.21 and its highest was $2.25 in the past 12 months.
What is Marpai’s market cap?
Marpai’s market cap is $56.91M.
When is Marpai’s upcoming earnings report date?
Marpai’s upcoming earnings report date is Aug 12, 2026 which is in 21 days.
How were Marpai’s earnings last quarter?
Marpai released its earnings results on May 13, 2026. The company reported -$0.129 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Marpai overvalued?
According to Wall Street analysts Marpai’s price is currently Overvalued.
Does Marpai pay dividends?
Marpai does not currently pay dividends.
What is Marpai’s EPS estimate?
Marpai’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marpai have?
Marpai has 25,292,667 shares outstanding.
What happened to Marpai’s price movement after its last earnings report?
Marpai reported an EPS of -$0.129 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.554%.
Which hedge fund is a major shareholder of Marpai?
Currently, no hedge funds are holding shares in MRAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Marpai Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $3.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-31.69%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-20.43%
Trailing 12-Months
Company Description
Marpai
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Technical Analysis
Ownership Overview
65.16% Insiders
0.08% Other Institutional Investors
34.76% Public Companies and
Individual Investors